Source: Annual Congress 2005 - Epidemiology and risk factors in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. V. Liverko (Tashkent, Uzbekistan). Role of beta2-agonists in the formation of carbohydrate metabolism disorders in the patients with asthma. Eur Respir J 2005; 26: Suppl. 49, 4327

Member's Comments

No comment yet.

Related content which might interest you: The rate of carbohydrate metabolism disorders in the patients with bronchial asthma Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Effect of carbohydrate metabolism disturbances on tolerence of physical load in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 638s Year: 2006 The pharmacogenetic aspects of corticosteroid metabolism in patients with severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 523s Year: 2006 Sensitivity and reactivity to exogenous insulin in the diagnosis of carbohydrate disorders in patients with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 420s Year: 2003 Sensitivity and reactivity to exogenous insulin in the diagnosis of carbohydrate disorders in patients with bronchial asthma Source: Annual Congress 2008 - Asthma control or asthma severity Year: 2008 Features of carbohydrate metabolism in patients with COPD Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Inhaled corticosteroids and β2-agonists reduces imbalance in the cellular redox status in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 508s Year: 2004 Peculiarities of calcium-phosphorus metabolism and lung function in patients with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 420s Year: 2003 The effect of inhaled and/or systemic corticosteroids on bone metabolism in asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Corticosteroids and beta2-agonists regulate pathologic homeostasis of hyaluronic acid in human airway smooth muscle cells from patients with asthma and COPD. Therapeutic relevance Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010 Clinical problems of comorbidity from a position of COPD and carbohydrate metabolism disorders Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Carbohydrate metabolism state in COPD patients Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 Role of Pgp in corticosteroid sensitivity in patients with severe forms of bronchial asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Effect of inhaled bronchodilators on the neurovegetative status of patients with bronchial asthma Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008 Features of chronic cough in patients with oxalate metabolism disorders Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006 Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006 Effects of intervention with high-dose inhaled corticosteroids on airway remodelling in diagnosed genetic variants of IL13 with asthma Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 The role of response to bronchodilators in differential diagnosis of COPD and asthma Source: Eur Respir J 2003; 22: Suppl. 45, 424s Year: 2003 Impaired glucose homeostasis in children with acute exacerbation of asthma is transitory Source: Eur Respir J 2001; 18: Suppl. 33, 42s Year: 2001 Inhaled corticosteroids decrease exercise-induced inflammation in patients with COPD Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease Year: 2007